ClinicalTrials.Veeva

Menu

Effect of Noninvasive High Frequency Oscillatory Ventilation on Improving CO2 Clearance in COPD Patients

G

Guangzhou Institute of Respiratory Disease

Status

Not yet enrolling

Conditions

Non-invasive Ventilation
COPD Exacerbation

Treatments

Device: Non-invasive high-frequency oscillatory
Device: Noninvasive Bilevel Positive Pressure Ventilation

Study type

Interventional

Funder types

Other

Identifiers

NCT05721833
GIRH-202203-1

Details and patient eligibility

About

High-frequency oscillatory ventilation (HFOV), as an ideal lung-protecting ventilation method, has been gradually used in neonatal critical care treatment, and is currently recommended as a rescue method for neonatal acute respiratory distress syndrome (ARDS) after failure of conventional mechanical ventilation. . Although its ability to improve oxygenation and enhance carbon dioxide (CO2) scavenging has been repeatedly demonstrated in laboratory studies, its impact on clinical outcomes in these patients remains uncertain. Non-invasive high-frequency oscillatory ventilation (nHFOV) combines the advantages of HFOV and non-invasive ventilation methods, and has become a current research hotspot in this field. It is recommended to be used to avoid intubation after conventional non-invasive ventilation therapy fails. For the treatment of intubation, there is still a lack of large-scale clinical trials to systematically explore its efficacy. The gradual increase in the clinical application of nHFOV has also enriched its use in the treatment of other diseases

Enrollment

12 estimated patients

Sex

All

Ages

40 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Age 40-80, males and females;
  2. Stage III and IV COPD and PaCO2≥50mmHg;
  3. Similar with non-invasive ventilation;
  4. Willing to participate in the study;
  5. Able to provide informed consent.

Exclusion criteria

  1. Bronchiectasis; post-tuberculosis sequelae; rib cage deformities; neuromuscular disorders; and bronchial carcinoma.
  2. Intolerant with NIV

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

12 participants in 2 patient groups

non-invasive high-frequency oscillatory ventilation
Experimental group
Description:
Patients were titrated for relevant parameters of non-invasive ventilation the day before the trial. In the non-invasive high-frequency oscillation ventilation mode, the support pressure is consistent with the non-invasive bi-level positive pressure mode, and the high frequency airway pressure oscillation driven by the solenoid valve is added during the expiratory phase. The amplitude is about 4cmH2O, and the oscillation frequency is about 8HZ.
Treatment:
Device: Non-invasive high-frequency oscillatory
Bilevel positive pressure ventilation
Active Comparator group
Description:
Patients were titrated for relevant parameters of non-invasive ventilation the day before the trial. Noninvasive bilevel positive pressure ventilation mode pressure titration follows previous studies.
Treatment:
Device: Noninvasive Bilevel Positive Pressure Ventilation

Trial contacts and locations

0

Loading...

Central trial contact

Rongchang Chen, PhD; Jianyi Niu, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems